Treatment of cancer or tumors induced by the release of heat generated by various chains of magnetosomes extracted from magnetotactic bacteria and submitted to an alternating magnetic field
A method for the treatment of tumor(s) or tumor cell(s) or cancer(s) in a subject in need by the generation of heat. The latter is produced by chains of magnetosomes extracted from whole magnetotactic bacteria and subjected to an alternating magnetic field. These chains of magnetosomes yield efficient antitumoral activity whereas magnetosomes unbound from the chains or kept within the whole bacteria produce poor or no antitumoral activity. The introduction of various chemicals such as chelating agents and/or transition metals within the growth medium of the bacteria improves the heating properties of the chains of magnetosomes. Moreover, the insertion of the chains of magnetosomes within a lipid vesicle is also suggested in order to favor their rotation in vivo and hence to improve their heating capacity. The vesicle can contain an antitumoral agent together with the chains of magnetosomes. In this case, the agent is released within the tumors by heating the vesicle.
1. A method of treating a tumor or tumor cells by heat therapy in a subject in need thereof, comprising administering to the subject chains of bacterial magnetosomes, wherein: (i) the chains of magnetosomes comprise maghemite, (ii) the chains of magnetosomes have been isolated from magnetotactic bacteria, (iii) the chains of magnetosomes have a lower surface charge at a pH of 10 than at a pH of 2, (iv) and most of the magnetosomes of the chains possess crystallographic directions orientated in the direction of the chain elongation.
2. The method according to claim 1 , wherein the chains of magnetosomes are subjected to an alternating magnetic field to yield the generation of heat.
3. The method according to claim 2 , wherein the magnetic field has a frequency between 50 kHz and 1000 kHz.
4. The method according to claim 2 , wherein the magnetic field has an amplitude between 0.1 and 200 mT.
5. The method according to claim 2 , wherein the magnetic field is applied during a time period varied between 1 second and 6 hours.
6. The method according to claim 2 , wherein the chains of magnetosomes are subjected to an alternating magnetic field to yield the generation of heat more than once.
7. The method according to claim 2 , wherein administering the chains of magnetosomes to said subject comprises administering the chains of magnetosomes within the tumor cells of said subject, and the alternating magnetic field increases the number of magnetosomes within the tumor cells.
8. The method according to claim 1 , wherein the chains of magnetosomes contain at least 2 magnetosomes.
9. The method according to claim 1 , wherein the magnetosomes contained within the chains possess sizes lying between 10 and 120 nm.
10. The method according to claim 1 , wherein the chains of magnetosomes have been obtained from magnetotactic bacteria that were cultivated in a growth medium containing a metal selected from the group consisting of iron, a transition metal other than iron, and a combination thereof.
11. The method according claim 1 , wherein the chains of magnetosomes have been obtained from magnetotactic bacteria that were cultivated in a growth medium containing a chelating agent.
12. The method according to claim 1 , wherein the chains of magnetosomes possess an agent used to visualize the chains of magnetosomes, said agent being a fluorophore or a fluorophore and a chelating agent, said agent being associated with the magnetosomes in a manner selected from the group consisting of (i) said agent being bound to the magnetosomes, (ii) said agent being incorporated within the magnetosomes and (iii) a combination thereof.
13. The method according to claim 1 , wherein the chains of magnetosomes are encapsulated within a vesicle, said vesicle being used in combination with an active principle.
14. The method according to claim 1 , wherein the treatment of the tumor cells or of the tumor is hyperthermia.
15. The method according to claim 14 , wherein the treatment is performed at a temperature between 37° C. and 45° C.
16. The method according to claim 1 , wherein the treatment of the tumor cells or of the tumor is thermoablation.
17. The method according to claim 16 , wherein the treatment is performed at a temperature between about 45° C. and about 100° C.
18. The method according to claim 1 , wherein targeting of the tumor or tumor cells by the chains of magnetosomes is carried out by using a magnetic field.
19. The method according to claim 1 , wherein targeting of the tumor or tumor cells is realized by attaching a biological or chemical targeting molecule which targets the tumor or tumor cells to the chains of magnetosomes or to a vesicle containing the chains of magnetosomes.
20. The method according to claim 19 , wherein, said biological or chemical targeting molecule being selected from the group consisting of an antibody, a PEG molecule, and a folic acid.
21. The method according to claim 1 , wherein said tumor is selected from the group consisting of prostate cancer, esophageal cancer, pancreatic cancer, breast cancer, brain cancer and skin cancer.
22. The method according to claim 1 , wherein, said method does not include a step of targeting the tumor or tumor cells by the chains of magnetosomes with a molecule targeting the tumor or tumor cells attached to the chains of magnetosomes.
23. A kit comprising chains of bacterial magnetosomes and a device, which is able to generate an alternating magnetic field, said chains of bacterial magnetosomes comprise maghemite, and have a lower surface charge at a pH of 10 than at a pH of 2.
24. The kit according to claim 23 , wherein the chains of magnetosomes are encapsulated within a vesicle.
25. A method for the production of chains of magnetosomes comprising cultivating magnetotactic bacteria in a growth medium containing at least an iron source with or without a chelating agent, wherein (i) said chains of magnetosomes comprise maghemite, (ii) said chains of magnetosomes have a lower surface charge at a pH of 10 than at a pH of 2, and (iii) most of the magnetosomes of said chains possess crystallographic directions orientated in the direction of the chain elongation.
26. Chains of bacterial magnetosomes isolated from magnetotactic bacteria, said chains obtained by the method according to claim 25 , wherein: (i) the magnetosomes comprise maghemite, (ii) most of the magnetosomes possess crystallographic directions orientated in the direction of the chain elongation, (iii) said chains having a lower surface charge at a pH of 10 than at a pH of 2.
27. The method according to claim 25 , further comprising extracting from the cultivated magnetotactic bacteria to obtain said chains of magnetosomes.
28. A composition comprising chains of bacterial magnetosomes isolated from magnetotactic bacteria wherein: (i) the magnetosomes comprise maghemite, (ii) most of the magnetosomes possess crystallographic directions orientated in the direction of the chain elongation, and (iii) the chains of bacterial magnetosomes have a lower surface charge at a pH of 10 than at a pH of 2.